HIV seroprevalence in five key populations in Europe: a systematic literature review, 2009 to 2019

Author:

Stengaard Annemarie Rinder1ORCID,Combs Lauren1,Supervie Virginie2ORCID,Croxford Sara3ORCID,Desai Sarika3,Sullivan Ann K4ORCID,Jakobsen Stine Finne1,Santos Quenia1ORCID,Simões Daniel56ORCID,Casabona Jordi78ORCID,Lazarus Jeffrey V9ORCID,de Wit John B F10ORCID,Amort Frank M11,Pharris Anastasia12ORCID,Nerlander Lina12ORCID,Raben Dorthe1

Affiliation:

1. Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

2. Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique, Paris, France

3. Independent consultant, London, United Kingdom

4. Directorate of HIV and Sexual Health, Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom

5. Grupo de Ativistas em Tratamentos (GAT), Lisboa, Portugal

6. EPIUnit–Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas, n° 135, Porto, Portugal

7. Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain

8. Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT), Barcelona, Spain

9. Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain

10. Department of Interdisciplinary Social Science, Utrecht University, Utrecht, Netherlands

11. FH JOANNEUM, University of Applied Sciences, Bad Gleichenberg, Austria

12. European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden

Abstract

Background In Europe, HIV disproportionately affects men who have sex with men (MSM), people who inject drugs (PWID), prisoners, sex workers, and transgender people. Epidemiological data are primarily available from national HIV case surveillance systems that rarely capture information on sex work, gender identity or imprisonment. Surveillance of HIV prevalence in key populations often occurs as independent studies with no established mechanism for collating such information at the European level. Aim We assessed HIV prevalence in MSM, PWID, prisoners, sex workers, and transgender people in the 30 European Union/European Economic Area countries and the United Kingdom. Methods We conducted a systematic literature review of peer-reviewed studies published during 2009–19, by searching PubMed, Embase and the Cochrane Library. Data are presented in forest plots by country, as simple prevalence or pooled across multiple studies. Results Eighty-seven country- and population-specific studies were identified from 23 countries. The highest number of studies, and the largest variation in HIV prevalence, were identified for MSM, ranging from 2.4–29.0% (19 countries) and PWID, from 0.0–59.5% (13 countries). Prevalence ranged from 0.0–15.6% in prisoners (nine countries), 1.1–8.5% in sex workers (five countries) and was 10.9% in transgender people (one country). Individuals belonging to several key population groups had higher prevalence. Conclusion This review demonstrates that HIV prevalence is highly diverse across population groups and countries. People belonging to multiple key population groups are particularly vulnerable; however, more studies are needed, particularly for sex workers, transgender people and people with multiple risks.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Subject

Virology,Public Health, Environmental and Occupational Health,Epidemiology

Reference100 articles.

1. European Centre for Disease Prevention and Control (ECDC)/World Health Organization (WHO) Regional Office for Europe. HIV/AIDS surveillance in Europe 2020 – 2019 data. Copenhagen: WHO/Europe; 2020. Available from: https://www.euro.who.int/en/publications/abstracts/hivaids-surveillance-in-europe-2020-2019-data

2. European Centre for Disease Prevention and Control (ECDC). HIV and men who have sex with men. Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report. Stockholm: ECDC; 2020. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/HIV-men-who-have-sex-with-men-Dublin-declaration.pdf

3. European Centre for Disease Prevention and Control (ECDC). HIV and people who inject drugs. Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report. Stockholm: ECDC; 2019. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/HIV-people-who-inject-drugs-Dublin-Declaration.pdf

4. The expanding epidemics of HIV type 1 among men who have sex with men in low- and middle-income countries: diversity and consistency.;Beyrer;Epidemiol Rev,2010

5. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.;Degenhardt;Lancet Glob Health,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3